The detail
Free testosterone and dihydrotestosterone (DHT) miniaturize scalp hair follicles. Pattern: thinning at crown and part line, sparing the hairline. Treatment combines anti-androgens (spironolactone), 5-alpha reductase inhibitors (finasteride off-label), and topical minoxidil. Addressing insulin resistance often improves androgen levels.
Historical context
Hair thinning in PCOS was frequently overlooked next to the more visible features (irregular cycles, acne, excess facial hair), yet for many women scalp hair loss is the most distressing symptom and the one that finally prompts a diagnosis.
Research landscape
PCOS-related scalp hair loss reflects androgen excess acting on genetically susceptible follicles: sensitive follicles miniaturize over successive cycles, producing the diffuse thinning over the crown typical of female-pattern hair loss. Because iron deficiency and thyroid disease cause similar thinning and are common in the same population, evaluation usually includes those. Treatments that lower androgen effect (for example anti-androgen therapy) or address the follicle directly (topical minoxidil) are used, and response is measured over many months because hair cycles are slow.
What providers actually do
Clinicians set expectations carefully: hair regrowth is gradual and partial, and the first goal is often to halt further loss. They also rule out the common mimics — iron, thyroid, and other causes — before attributing thinning solely to PCOS.
Subtle red flags specific to this question
- Patchy, well-circumscribed bald spots rather than diffuse thinning — points to alopecia areata, not androgenic loss.
- Rapidly progressive hair loss with deepening voice or other virilizing signs — evaluate promptly for a significant androgen source.
- Scalp scaling, redness, or scarring — a dermatologist should assess for a scarring alopecia.
- Thinning with severe fatigue or heavy periods — check iron studies and thyroid function.
Sources
Was this helpful?